People Move: Aziz Mottiwala Named President and CEO of RxSight

Aziz Mottiwala has spent twenty years learning how surgeons decide. He just took over the company that needs them to decide differently, and that is a leader walking straight at the hard part.

RxSight, Inc. (Nasdaq: RXST), the Aliso Viejo medical technology company behind the Light Adjustable Lens, has appointed Aziz Mottiwala as President and Chief Executive Officer, effective July 20, 2026, per the company’s announcement and its Form 8-K filed with the SEC. He succeeds Ron Kurtz, M.D., the physician-entrepreneur who led the company through commercialization and who now continues as Chief Medical Officer.

Mottiwala arrives from Tarsus Pharmaceuticals in Irvine, where he served as Chief Commercial Officer from 2020 and helped carry the company from clinical-stage promise to commercial-stage reality in one of eye care’s most closely watched launches. Before Tarsus he held the same title at Opiant Pharmaceuticals, and before that he spent more than a decade at Allergan in senior leadership across its eye care franchise and its broader commercial organization. He has spent his entire professional life learning how patients, surgeons, and payers actually decide, and he has now been handed a company whose technology is genuinely different but whose next chapter is entirely about adoption.

The detail worth pausing on is not who arrived. It is who stayed. Ron Kurtz co-founded LenSx Lasers before RxSight, and he led this company through the years when the Light Adjustable Lens went from an audacious idea to an FDA-cleared product in surgeons’ hands. Founders in that position usually exit with a board seat and a wave goodbye. Kurtz moved into the Chief Medical Officer role instead, which means the clinical conscience of the company stays in the building while a commercial operator takes the wheel.

That structure tells you the board did not lose faith in the science. It decided the bottleneck had moved. When a company keeps its founder close and hires a commercial chief executive, it is announcing that the hard question is no longer whether the thing works. It is how many surgeons can be persuaded to change how they practice, and how fast.

Because the sell is genuinely harder than the science. The Light Adjustable Lens is the only intraocular lens that can be customized after cataract surgery, letting a surgeon refine a patient’s vision once the eye has healed. That is not an incremental feature, it is a different premise for how the procedure works. Surgeons have to adopt new workflow, practices have to invest in equipment, and patients have to be walked through a concept nobody has ever explained to them. That is a commercial problem, not a clinical one, and it is precisely the problem Mottiwala has solved before. Launching a first-in-category product at Tarsus meant building a market rather than taking share in one that already existed.

For the boards reading this, the lesson generalizes. Hiring the right leader is never about the most impressive resume in the stack. It is about matching the person to the specific constraint the company faces right now, which is the discipline behind why your next VP hire will make or break your next five years. RxSight had a science problem and hired a scientist. It now has a scale problem and hired a scaler. That is not luck, that is a board doing its job.

Here is the part that should make every Southern California executive sit up. Mottiwala never had to leave the region to build this career. Allergan was headquartered in Irvine for decades. Tarsus sits in Irvine. RxSight sits in Aliso Viejo, about twenty minutes down the 5. An entire path from senior commercial leader to chief executive, inside a fifteen mile radius of Orange County. That is what real talent density looks like, and it is the quiet economic story of this region. The ophthalmic device cluster here grew out of Allergan’s long shadow, and the people that company trained have seeded a generation of companies around it. When a market reaches that depth, executives stop treating relocation as the price of ambition, and boards stop assuming they have to recruit from Boston or the Bay Area to find someone who has done it before. That is Southern California’s talent renaissance showing up in a public filing.

Look at the shape of the path, too, because it argues against the advice most ambitious professionals are given. Mottiwala did not collect industries. He did not hop every eighteen months to manufacture the appearance of momentum. He went deep in one therapeutic area and stayed long enough for the compounding to work. A decade-plus at a giant taught him how large commercial organizations actually run. Two chief commercial officer seats at smaller companies gave him a scoreboard he personally owned. By the time the CEO seat opened he was not a candidate with adjacent experience. He was the obvious answer. Depth held long enough becomes leverage, and it is the same pattern in nearly every executive search we run: the strongest candidates are rarely the most restless ones. If you are building that bench inside your own company, the long game is the only game.

The first ninety days will tell the market a great deal. How he talks to surgeons. What he does with the commercial organization. Whether adoption accelerates on his watch. New executives rarely fail for lack of talent, they fail for lack of a clear first act, which is the trap mapped in the 90-day rule. Mottiwala has the advantage of knowing this customer base cold and the disadvantage of inheriting a category he now has to expand rather than invent.

Congratulations, Aziz. Twenty years building commercial engines, and now the entire machine is yours. Aliso Viejo is lucky to have you.

Know a leader who deserves this spotlight?

This is what we do at Recruiter Hustle: we don’t just report the move, we honor the person behind it. If you, your company, or someone you admire just stepped into a new chapter, we want to tell that story right. Follow every appointment on our People Moves Tracker.

→ Submit a People Move • or reach out to Cathy Trinh directly, and let’s put your name in the light.

HEART. HUMAN. HUSTLE.

Cathy Trinh

recruiterhustle.com

Chief Talent Strategist & Editor-in-Chief | 26-year global recruiting veteran, #1 bestselling author, cancer survivor & humanitarian. Founder of Recruiter Hustle, OC/LA's no-filter media platform for talent, finance & recruiting professionals. Heart. Human. Hustle.

More from Cathy Trinh →